Found 289 matching trials
Safety and Feasibility of Autologous Endothelial Progenitor Cells Transplantation in Patients With Idiopathic Pulmonary Arterial Hypertension NA Recent researches indicate that impairment of vascular and endothelial home...
Show More Location
Department of Cardiology, the First Affiliated Hospital, College of Medicine, Zhejiang University
Learn More & Join Trial
Randomized Controlled Trial of Fecal Microbiota Transplantation in Severe Obesity NA This is a randomized, double-blinded and placebo controlled prospective tri...
Show More Location
University Hospital of North Norway
Learn More & Join Trial
Comparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast Cancer PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Herbert Irving Comprehensive Cancer Center
Learn More & Join Trial
Lenalidomide, Adriamycin, Dexamethasone (RAD) Versus Lenalidomide, Bortezomib, Dexamethasone (VRD) for Induction in Newly Diagnosed Multiple Myeloma Followed by Response-adapted Consolidation and Lenalidomide Maintenance PHASE3 The investigators propose this study utilizing Lenalidomide, Adriamycin, De...
Show More Location
Universitätsklinikum Aachen, Med. Klinik IV, Hämatologie u. Onkologie
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
Reducing Hemarthrosis in ACL Reconstruction With BTB Autograft by the Administration of Intravenous TXA PHASE4 The purpose of the proposed study is to evaluate the effects of administeri...
Show More Location
New York University School of Medicine
Learn More & Join Trial
BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL PHASE3 This is a randomized, open-label, prospective, multicenter phase III superi...
Show More Location
Fudan University Shanghai Cancer Center,
Learn More & Join Trial
Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction NA All patients will be randomly assigned using a computer randomization algor...
Show More Location
Banner University Medical Center Phoenix
Learn More & Join Trial
"One-step" Bone Marrow Mononuclear Cell Transplantation in Talar Osteochondral Lesions NA BACKGROUND Osteochondral lesions are defects of the cartilaginous surface a...
Show More Location
I Clinic, Rizzoli Orthopaedic Institute
Learn More & Join Trial
A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients PHASE1 This study is testing a combination of chemo-immuno therapy called RBM. RBM...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial